Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Sodium hyaluronate 0.2% eye drops |
| Virtual Therapeutic Moiety | Sodium hyaluronate |
| Basis of preferred name | BANM - British Approved Name (Modified) |
| Prescribing status | Caution - AMP level prescribing advised |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Not applicable |
| Dose Form | |
|---|---|
| Formulation | Eye drops |
| Drug Route | |
| Route | Ocular |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Aactive HA 0.2% eye drops (TriOn Pharma Ltd) | |
| AaqEye HA 0.2% eye drops (Essential-Healthcare Ltd) | |
| Blink Intensive Tears 0.2% eye drops (AMO UK Ltd) | |
| Xailin HA 0.2% eye drops (Visufarma UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Sodium hyaluronate 0.2% eye drops 10 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.